首页    期刊浏览 2024年09月21日 星期六
登录注册

文章基本信息

  • 标题:THE SEQUENTIAL TREATMENT FOR HELICOBACTER PYLORI ERADICATION AS A FIRST-LINE THERAPY IN TYPE 2 DIABETIC PATIENTS
  • 本地全文:下载
  • 作者:Amelia GENUNCHE-DUMITRESCU ; Daniela BADEA ; Cristian MARINAS
  • 期刊名称:Research and Science Today
  • 印刷版ISSN:2247-4455
  • 电子版ISSN:2285-9632
  • 出版年度:2020
  • 期号:20
  • 页码:175-179
  • DOI:10.38173/RST.2020.20.2.18:175-179
  • 语种:English
  • 出版社:RST Journal
  • 摘要:HELICOBACTER PYLORI (HP) IS A GRAM NEGATIVE BACTERIUM FOUND IN THE STOMACH AND DETERMINED CHRONIC GASTRITIS, PEPTIC ULCERS AND GASTRIC CANCER.IN PATIENTS WITH DIABETUS MELLITUS THE FREQUENCY OF HELICOBACTER PYLORI INFECTION WAS HIGHER COMPARATIV WITH NONDIABETICS.HELICOBACTER PYLORI INFECTION MAY INCREASE THE LEVEL OF GLYCOSYLATED HEMOGLOBIN IN DIABETIC PATIENTS.THE LEVELS OF GLICEMIA WAS CONTROLLED BY INSULIN OR ORAL HYPOGLICEMIC AGENTS WHILE THE DRUGS USED FOR ERADICATION OF HP INFECTION ARE PROTON PUMP INHIBITORS, BISMUTH COMPOUNDS, METRONIDAZOLE, CLARITHROMYCIN, AMOXICILIN AND TETRACYCLINE.
  • 关键词:HELICOBACTER PYLORI;DIABETUS MELLITUS
国家哲学社会科学文献中心版权所有